Sherlock Biosciences’ Post

🌟 Exciting News Alert! 🌟 I am thrilled to share that the founder of Bharat Biotech, Dr. Krishna Ella, has been honored by Johns Hopkins for his incredible contributions to public health! 🏆👏 Dr. Ella's relentless efforts in the field of biotechnology have led to groundbreaking advancements in public health, especially in the areas of vaccine development and infectious disease control. His visionary leadership and commitment to scientific excellence have undoubtedly made a significant impact on global health and wellness. This recognition by Johns Hopkins University truly underscores Dr. Ella's exceptional dedication to improving public health on a global scale. It's a testament to his tireless work and unwavering passion for making a positive difference in the world. Let's all congratulate and celebrate Dr. Krishna Ella for this well-deserved recognition and for his outstanding contributions to public health! 🎉👨🔬🌍 #BharatBiotech #DrKrishnaElla #JohnsHopkins #PublicHealth #Biotechnology #GlobalHealth #Recognition #Congratulations Note: AI-powered post. May contain errors.

Is Health Data Norways new gold? Last preparations for my talk today about how the phameceutical industry and companies like Novartis, are important enablers for doing more research and building health industry from the use of health data. 👉 Norwegian data are unique and must be utilized 👉 The industry is ready to invest 👉 We need political anchored concrete next steps to build a WORLD-LEADING health infrastructure Novartis Norge Oslo Science City Legemiddelindustrien (LMI) The Life Science Cluster Oslo Cancer Cluster SINTEF NMBU - Norwegian University of Life Sciences Oslo universitetssykehus

Watch the 30min webinar https://ow.ly/Y1Jw50RnOzs What are the exceptions in health care? And what are the exceptional exceptions? Learn more about JOHCM Global Select https://ow.ly/lqbN50RnOB1 Christopher Lees Nudgem Richyal #JOHCM #GlobalEquities #Healthcare

Today, on February 29th, we join the global #community in commemorating World #Rare Disease Day, a vital initiative to amplify #awareness around the harsh realities of these often-overlooked #pathologies. At NANOMOL TECHNOLOGIES, we are resolute in our dedication to creating awareness and addressing the significant challenges posed by rare #diseases. 🌐 Global #Health Implications: Rare diseases pose a profound #challenge to global public health. With limited understanding, resources, and #treatment options, individuals with rare diseases face substantial hurdles in obtaining timely and effective #care. The struggle is not only a personal one but also extends to the broader #healthcare ecosystem:   ➡Over 300 million people #worldwide suffer from a rare disease.  ➡72% of rare diseases are #genetic in origin, affecting individuals from birth.  ➡The lack of scientific #knowledge often delays #diagnosis and treatment, exacerbating the impact on #patients. 🔬 Innovating in Real-Time: We reaffirm our ongoing commitment to nanomedicine #research, #development, and GMP #manufacturing. In the present moment, we actively immerse ourselves in the #development of nanomedicine, adhering to #GMP standards. Our mission is to pioneer advanced and effective treatments for #Fabry disease, contributing to a substantial improvement in the lives of individuals grappling with the #challenges of rare diseases. Together, we are shaping a present filled with hope and enhancing the #quality of life for individuals affected by rare diseases.    #WorldRareDiseaseDay #GlobalHealthChallenge #Innovation #Nanomedicine #FabryDisease 

Access to healthcare in rural areas remains a significant challenge. The recent Science Cafe discussion highlights the innovative approaches being taken to address these disparities and improve health outcomes for rural communities. Improving rural health is critical for achieving equitable healthcare for all. Let's continue to support and innovate in this vital area. 💬 What are your thoughts on enhancing rural healthcare? Have you seen effective solutions in action? Link: https://lnkd.in/esR8-k9S #RuralHealth #Telehealth #HealthcareInnovation #CommunityHealth #EquitableHealthcare #AccessToCare

𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗔𝗻𝗻𝗼𝘂𝗻𝗰𝗲𝗺𝗲𝗻𝘁! 📎 Get ready to revolutionize the fight against antimicrobial resistance with MaxImmun!   𝗪𝗵𝗼? 🇪🇺 The MaxImmun project brings together 6 partners from 3 European countries, uniting to combat antimicrobial resistance.   𝗪𝗵𝗮𝘁? 🧬 MaxImmun is an innovative initiative aimed at tackling antimicrobial resistance by stimulating the immune response and enhancing the expression of natural antimicrobial peptides in humans, using molecules inspired by marine biodiversity.   𝗛𝗼𝘄? 🔬 The project utilizes novel immuno-modulatory molecules to induce therapeutic expression of host antimicrobial peptides, without triggering inflammation. Instead of directly targeting a pathogen with exogenous antibiotics, this innovative approach fosters a natural endogenous response within the human body.   𝗪𝗵𝘆? 🌍 Antimicrobial resistance is a global health threat, responsible for 1.27 million deaths worldwide in 2019. With the development of new antimicrobials at a standstill, there's an urgent need for innovative therapeutic strategies to combat infections and reduce the spread of antimicrobial resistance.   𝗪𝗵𝗲𝗻? 🕒 The MaxImmun project is scheduled to run from January 2024 to December 2027, with a budget of €3.2 million. Its launch represents a crucial step in the fight against antimicrobial resistance, offering a sustainable and promising solution to safeguard global health.   𝗪𝗵𝗮𝘁'𝘀 𝗡𝗲𝘅𝘁? 🗞️ Stay tuned for our upcoming website launch, where you can delve deeper into MaxImmun's mission and impact!   Follow MaxImmun for updates on our fight against antimicrobial resistance. P͟a͟r͟t͟n͟e͟r͟s͟ Brice Sperandio, PhD Mark Broenstrup Dan Anderson Nathalie Vergnolle Al-Mourabit Ali École normale supérieure Helmholtz-Gemeinschaft / Helmholtz Association Uppsala University Inserm  CNRS - Centre national de la recherche scientifique  IMMUNRISE BIOCONTROL FRANCE E͟x͟t͟e͟r͟n͟a͟l͟ ͟A͟d͟v͟i͟s͟o͟r͟y͟ ͟B͟o͟a͟r͟d͟ Gilles Courtemanche Antoine Alam Fabienne Venet Anne Buisson #MaxImmun #AMR #Innovation #Europe #Healthcare  

Lactobacillus iners is found in women with optimal and dysbiotic vaginal microbiota. Unlike other lactobacilli which contribute to maintaining a healthy environment by lowering the vaginal pH, L. iners produces relatively small amounts of lactic acid and can coexist with pathogenic bacteria, potentially facilitating conditions like bacterial vaginosis. Moreover, its resistance to metronidazole enables it to persist favouring a return to a dysbiotic state, even after antibiotic treatment. Understanding its complex interactions is crucial for advancing our knowledge of vaginal health and developing effective therapies. Bill & Melinda Gates Foundation Gift4Africa Science for Africa Foundation Kenya Medical Research Institute (KEMRI) Desmond Tutu Health Foundation University of Cape Town

A thorough #market #analysis is the cornerstone of success for innovative ideas. But what information is necessary to launch a product that brings tangible benefits to citizens and patients? In the WARIFA Project, CiaoTech - Gruppo PNO - leading European company in #innovation management, and responsible for Exploitation & Dissemination activities of WARIFA - carried out a #TechnologyIntelligence study to support the market introduction of a new, clinically validated tool and app designed to combat non-communicable diseases that affect many people on average: diabetes, cardiovascular and pulmonary diseases, skin cancer, and poor lifestyle choices. CiaoTech - Gruppo PNO’s work identified key trends and opportunities in the European market for personalized prevention, locating over 200 associations of doctors and patients, hospitals, and distributors of personal wellness devices. Discover more by reading the article published by CiaoTech - Gruppo PNO! 🔗 https://lnkd.in/dPmuhzrQ Norwegian Centre for E-health Research CiaoTech - Gruppo PNO INNOVATION PLACE Consiglio Nazionale delle Ricerche Universidad de Las Palmas de Gran Canaria UiT Norges arktiske universitet Fundación Canaria de Investigación y Salud y Servicio de Evaluación del Servicio Canario de la Salud Evaluation Unit of the Canary Islands Health Service Canary Islands Health Research Institute Foundation Universitetet i Oslo (UiO) Munster Technological University NetSun Software Universidad Rey Juan Carlos Sensotrend #health #ehealth #chronicconditions #artificialintelligence

CCD stands as a critical global health concern, acknowledged as a priority by healthcare experts. A notable disparity in public awareness and funding support for research in this area has led to a lack of attention and resources, hampering advancements in understanding the mechanisms, immunopathogenesis, risk factors, and clinical evolution of CCD. A comprehensive understanding of CCD is essential for the development of targeted therapeutics aimed at mitigating its global societal and economic impact. Increasing awareness among the public, government, and non-governmental organisations is crucial to gaining the necessary support for more research focused on combating the challenges posed by CCD

This important event marked the end of JANE-1 and the transition to the new Joint Action on Networks of Expertise on Cancer (JANE-2). As leader, together with my colleague João Macedo from the Centro de Oncologia dos Açores, of the task on "Health Policies" of JANE-2's Network of Expertise (NoE) on Personalised Primary and Secondary Cancer Prevention, I find it particularly important and relevant to get the message out to the political stakeholders. The NoE on Personalised Primary and Secondary Cancer prevention will be comitted to "advancing individualised strategies to prevent disease by integrating genetic, lifestyle and environmental factors into healthcare approaches". #HealthUnion #EUCancerPlan #EUBeatingCancerPlan #cancer #oncology JANE- EU Joint Action on Networks of Expertise on Cancer Faculdade de Medicina da Universidade do Porto Centro de Oncologia dos Açores Direção-Geral da Saúde RISE - Health Research Network CraNE Join Action